👋 Meet the #SuperBugSolution...
82% of patients that have received phage therapy at UCSD have had a clinically successful outcome, the highest reported successful series in the US! Patients from the U.S. and across the globe seek out IPATH because we are a leader in the fight against antibiotic-resistant infections.
With your support, IPATH can increase the accessibility of phage therapy and offer hope to patients worldwide in their battle against antibiotic-resistant infections.
And, you can give based on your interest! We have giving funds set up for Research, Clinical, and General Support.